Postoperative Radiotherapy in Pathological T2–3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study

BACKGROUND: The role of postoperative radiotherapy in pathological T2–3N0M0 esophageal squamous cell carcinoma is unknown. We aimed to evaluate the efficacy and safety of postoperative radiotherapy in patients with pathological T2–3N0M0 thoracic esophageal squamous cell carcinoma. MATERIALS AND METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Deng, Wei, Yang, Jinsong, Ni, Wenjie, Li, Chen, Chang, Xiao, Han, Weiming, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Lv, Jima, Wang, Xiaozhen, Wang, Xin, Deng, Lei, Wang, Wenqing, Bi, Nan, Zhang, Tao, Li, Yexiong, Gao, Shugeng, Xue, Qi, Mao, Yousheng, Sun, Kelin, Liu, Xiangyang, Fang, Dekang, Wang, Dali, Li, Jian, Zhao, Jun, Shao, Kang, Li, Zhishan, Chen, Xinjie, Han, Lei, Wang, Lifang, He, Jie, Xiao, Zefen
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Radiation Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160414/
https://ncbi.nlm.nih.gov/pubmed/32083766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados